Business Award - November 17, 2021
Nanoform wins Star of Innovation award
Nanoform Finland has won the Star of Innovation award at the 9th annual European Small and Mid-Cap Awards. The award win recognizes Nanoform as a listed company that places innovation at the center of its strategy for business development and introduces an innovative technology to the market. On the same night, November 16th 2021, Nanoform […]
Financing - October 4, 2021
Nanoform receives funding from the Bill & Melinda Gates Foundation
Nanoform has announced that Proof of Concept studies will be funded by the Bill & Melinda Gates Foundation. The funding will be used to assess the added value Nanoform’s CESS nanoparticle engineering technology can deliver to several of its drug development projects. “Our goal is to improve the lives of over 1 billion patients. We […]
Agreement - August 6, 2021
Nanoform and Boehringer Ingelheim execute master services agreement
The two companies have executed a master services agreement (MSA) to initiate projects in the pre-clinical early development space. The aim with the agreement is to solve the challenge of poor bioavailability and solubility in new drug candidates. “Wider uptake of the latest technological innovations is essential to address the low success rates for new […]
Collaboration - May 27, 2021
Nanoform and Celanese announce plans to collaborate
Nanoform and Celanese Corporation have announced plans to explore the synergies between their respective technologies in the field of nanoparticle-enabled drug delivery. The goal is to assess the utility of combining Nanoform’s nanoparticle platform technologies with Celanese’s VitalDose EVA copolymer delivery technology for drug-eluting implants, states Nanoform in a press release. The aims are to […]
Clinical Trials - May 21, 2021
Nanoform announces new clinical results
Nanoform has announced the completion and final results of its clinical study. The primary, secondary and optional exploratory objectives of the study were all met. The results show that Nanoform’s CESS technology enabled development of a fast-acting piroxicam immediate release (IR) tablet formulation with more rapid absorption and improved drug delivery performance in comparison to […]
Collaboration - April 22, 2021
Nanoform and Aprecia enter collaboration
The two companies are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms. This collaboration seeks to provide customers and the pharmaceutical industry with new capabilities in patient centric therapies, they state in a press release. The immediate product innovation target for the collaboration is to combine Nanoform’s fast […]
